MedImmune and Sanofi Pasteur are creating and marketing MEDI8897, a drug that aims to prevent lower respiratory tract illnesses that stem from respiratory syncytial virus.

Aeolus Pharmaceuticals Inc. recently started a Phase 1 test of AEOL 10150 on healthy people as part of its efforts to determine whether it can delay the effects of acute radiation exposure in the lungs.

Recent test results from Shire's CUVITRU show the treatment has performed well in helping those whose immune system is not complete or do not work as it should.

GlaxoSmithKline and Innoviva Inc. recently reported that patients whose asthma was well-controlled could use Relvar Ellipta once per day, which is less frequent than other treatments.

ViiV Healthcare recently found in phase III testing that the combination of dolutegravir and rilpivirine is as effective in treating HIV as a three- or four-drug combination.

Close to a quarter of patients treated in emergency rooms face out-of-pocket costs, often extremely high, because they unknowingly are treated by out-of-network doctors, a new study reveals.

Sanofi Genzyme recently observed Rare Disease Day with events at its locations around the world.

Medical professionals are calling on people to learn how to identify depression in teenagers.

University of Colorado scientists have discovered that the immune system may get in the way of the body fighting HIV-1.

The American Heart Association (AHA) is applauding a House fiscal 2018 funding bill that directs an additional $6 million to the Centers for Disease Control's Division for Heart Disease and Stroke Prevention and $4 million to the Million Hearts Program national initiative.

The American Hospital Association (AHA) recently recognized the University of Utah Health with its Most Wired award.

A University of North Carolina (UNC) family medicine doctor and researcher has released a book that uses the newest clinical results in providing care for people with Alzheimer's disease and dementia.

The American Academy of Family Physicians (AAFP) is joining the National Academy of Medicine to help promote a program that prioritizes the well-being of physicians, called the Action Collaborative on Clinician Well-Being and Resilience.

Wake Forest Baptist Medical Center and Wake Forest University researchers are coming together to determine whether improvisational dance could help those with dementia and boost quality of life.

The recent 2017 Sleep and Breathing Symposium in Madison, Wisconsin, brought together sleep researchers from around the world to share insight from their research and trials.

The University of Pittsburgh School of Medicine has signed a contract with highly respected French medical institutions to collaborate on research in medicine and biomedical sciences.

The University of Pittsburgh will give biologist Dr. David M. Sabatini the 2017 Dickson Prize in Medicine.

The Wisconsin Alzheimer's Disease Research Center is accepting applications for its Alzheimer’s Disease Pilot Grant Program, which supports pilot testing of studies related Alzheimer's disease.

With the U.S. being the world leader in the area of life-sciences innovation, having created 57 percent of new chemical entities from 2001-2010, it is difficult to believe that 95 percent of the rare diseases in the U.S. do not have a single FDA-approved treatment; yet this is a reality that Stephen Ezell, vice president of global innovation policy with the Information Technology and Innovation Foundation (ITIF), is seeking to bring to light.

OncLive 2017 recently named melanoma research expert Dr. John Kirkwood one of its Giants of Cancer Care.